Uncategorized
ReVision Optics Secures $10 Million Credit Facility from Square 1 Bank
LAKE FOREST, Calif. & SAN DIEGO--(BUSINESS WIRE)--ReVision Optics®, Inc. (RVO), a leader in implantable presbyopia-correcting corneal inlay technology, today announced that it has secured a $10 million credit facility from Square 1 Bank, a division of Pacific Western Bank. RVO announced receipt of U.S. Food and Drug Administration (FDA) approval for its Raindrop® Near Vision Inlay for the surgical correction of presbyopia on June 29, 2016. Proceeds from the credit facility will be used for work
